{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:45:30Z","timestamp":1782989130402,"version":"3.54.5"},"reference-count":29,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Qingdao Key Health Discipline Development Fund","award":["2020B047"],"award-info":[{"award-number":["2020B047"]}]},{"name":"China Association for Science and Technology Graduate Science Communication Ability Promotion Project","award":["No. kxyjskpxm2019024 and kxyjskpxm2019055"],"award-info":[{"award-number":["No. kxyjskpxm2019024 and kxyjskpxm2019055"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Assessing the knowledge, attitude and practices (KAP) regarding health self-management among patients with osteogenesis imperfecta (OI) in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>An online cross-sectional survey.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>A structured questionnaire was distributed online through China-Dolls Center for Rare Disorders (CCRD), a non-governmental charity in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Participants were all patients with OI from CCRD. After stratified sampling according to the economic level of residential city, 901 patients were proportionally selected and 869 patients completed the survey (response rate: 96.4%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Demographic characteristics and KAP information were gathered using a 5-point Likert scale. The score of each dimension of KAP was the sum of the scores of all included items. \u03a7<jats:sup>2<\/jats:sup> test or Fisher\u2019s exact test was used to compare scores of different items. Ordinal regression was employed to determine the significant factors influencing KAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 802 questionnaires were included for analysis. Male respondents accounted for 57.1%, and 29.1% of respondents were of 26~30 years. More than half (50~60%) of patients knew the main symptoms of OI and the treatment of OI-related complications. Almost 80% of patients showed positive attitude. Nearly 60~70% of the patients were relatively able to take appropriate practice regarding OI management. There was a significant correlation between scores of knowledge and attitude, attitude and practice, as well as knowledge and practice. Patients aged 26~30 years, from urban areas and big cities, had higher KAP scores. Male patients showed better performance in knowledge, and highly educated patients perform better in practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with OI did not have sufficient knowledge on disease care and up-to-date caring guidelines, and their practice regarding health self-management also needs to be improved. Gender, age, educational level and economic level of residence can affect the level of KAP for patients, thus developing targeted and tailored programmes for patients with OI is highly recommended.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-046286","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T17:22:21Z","timestamp":1632763341000},"page":"e046286","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Knowledge, attitude and practices regarding health self-management among patients with osteogenesis imperfecta in China: an online cross-sectional survey"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2242-0917","authenticated-orcid":false,"given":"Yongjie","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijia","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-kit","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-313X","authenticated-orcid":false,"given":"Yibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"2021092710000789000_11.9.e046286.1"},{"key":"2021092710000789000_11.9.e046286.2","unstructured":"China-Dolls Center for Rare Disorders . A survey report on the survival status of patients with osteogenesis imperfecta in China, 2013. Available: http:\/\/chinadolls.org.cn\/attachment\/download?id=28 [Accessed 23 April 2020]."},{"key":"2021092710000789000_11.9.e046286.3","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2021092710000789000_11.9.e046286.4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.metabol.2017.06.001","article-title":"Osteogenesis imperfecta - A clinical update","volume":"80","author":"Tournis","year":"2018","journal-title":"Metabolism"},{"key":"2021092710000789000_11.9.e046286.5","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36545"},{"key":"2021092710000789000_11.9.e046286.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2009.10.007"},{"key":"2021092710000789000_11.9.e046286.7","first-page":"52","article-title":"Health management in children with osteogenesis imperfecta","volume":"2","author":"Li H-J","year":"2020","journal-title":"TMR Aging"},{"key":"2021092710000789000_11.9.e046286.8","first-page":"367","article-title":"Current and emerging treatments for the management of osteogenesis imperfecta","volume":"6","author":"Monti","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"2021092710000789000_11.9.e046286.9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/JMDH.S113483","article-title":"Managing the patient with osteogenesis imperfecta: a multidisciplinary approach","volume":"10","author":"Marr","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"2021092710000789000_11.9.e046286.10","doi-asserted-by":"crossref","unstructured":"Ralston SH , Gaston MS . Management of osteogenesis imperfecta. Front Endocrinol 2020;10:924. doi:10.3389\/fendo.2019.00924","DOI":"10.3389\/fendo.2019.00924"},{"key":"2021092710000789000_11.9.e046286.11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11914-017-0401-0","article-title":"Long-term bisphosphonate therapy in osteogenesis imperfecta","volume":"15","author":"Biggin","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"2021092710000789000_11.9.e046286.12","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1515\/jpem-2020-0260","article-title":"Treatment response to long term antiresorptive therapy in osteogenesis imperfecta type VI: does genotype matter?","volume":"33","author":"Celik","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021092710000789000_11.9.e046286.13","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1097\/MJT.0000000000000236","article-title":"Efficacy of bisphosphonates on bone mineral density and fracture rate in patients with osteogenesis imperfecta: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Am J Ther"},{"key":"2021092710000789000_11.9.e046286.14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ajmg.c.31532","article-title":"Pharmacological and biological therapeutic strategies for osteogenesis imperfecta","volume":"172","author":"Marom","year":"2016","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2021092710000789000_11.9.e046286.15","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.E.00333"},{"key":"2021092710000789000_11.9.e046286.16","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s11136-016-1247-0","article-title":"The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review","volume":"25","author":"Tsimicalis","year":"2016","journal-title":"Qual Life Res"},{"key":"2021092710000789000_11.9.e046286.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-961"},{"key":"2021092710000789000_11.9.e046286.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2014.11.012"},{"key":"2021092710000789000_11.9.e046286.19","unstructured":"Dong ZB . Research on osteoporosis imperfecta survival status, needs and security. [In Chinese. Shandong University, 2018."},{"key":"2021092710000789000_11.9.e046286.20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00198-018-4801-5","article-title":"Health-related quality of life in children with osteogenesis imperfecta: a large-sample study","volume":"30","author":"Song","year":"2019","journal-title":"Osteoporos Int"},{"key":"2021092710000789000_11.9.e046286.21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.dhjo.2018.12.003","article-title":"Exploring the impact of osteogenesis imperfecta on families: a mixed-methods systematic review","volume":"12","author":"Hill","year":"2019","journal-title":"Disabil Health J"},{"key":"2021092710000789000_11.9.e046286.22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00774-019-01033-9","article-title":"Impact of fracture characteristics and disease-specific complications on health-related quality of life in osteogenesis imperfecta","volume":"38","author":"Matsushita","year":"2020","journal-title":"J Bone Miner Metab"},{"key":"2021092710000789000_11.9.e046286.23","unstructured":"Chinese Organization for Rare Disorders . Reports on drug access for rare disease, 2019. Available: http:\/\/www.raredisease.cn\/source!downSource?id=8a9d475463869c1901692e1b43ac049e [Accessed 23 Apr 2020]."},{"key":"2021092710000789000_11.9.e046286.24","unstructured":"Huazhong University of Science and Technology. . An investigation report on rare diseases in China, 2018. Available: http:\/\/images.cdb.org.cn\/editor\/20180228\/files\/2018%E7%BD%95%E8%A7%81%E7%97%85%25%20E8%B0%83%E7%A0%94%E6%8A%A5%E5%91%8A.pdf [Accessed 23 April 2020]."},{"key":"2021092710000789000_11.9.e046286.25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1080\/09638288.2017.1334236","article-title":"Family experience with osteogenesis imperfecta type 1: the most distressing situations","volume":"40","author":"Santos","year":"2018","journal-title":"Disabil Rehabil"},{"key":"2021092710000789000_11.9.e046286.26","unstructured":"Jones T , Theophile I , Price A . Barriers impacting on participation in physical activity for children with osteogenesis imperfecta: a study of child and parent perspectives. Cape Town, South Africa: Abstract from World Confederation of Physical Therapy Congress, 2017."},{"key":"2021092710000789000_11.9.e046286.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147654","article-title":"Involving families with osteogenesis imperfecta in health service research: joint development of the OI\/ECE questionnaire","volume":"11","author":"Dogba","year":"2016","journal-title":"PLoS One"},{"key":"2021092710000789000_11.9.e046286.28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-13-153","article-title":"The impact of severe osteogenesis imperfecta on the lives of young patients and their parents - a qualitative analysis","volume":"13","author":"Dogba","year":"2013","journal-title":"BMC Pediatr"},{"key":"2021092710000789000_11.9.e046286.29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-017-0301-4","article-title":"Health-related quality of life in adults with osteogenesis imperfecta","volume":"101","author":"Hald","year":"2017","journal-title":"Calcif Tissue Int"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-046286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T17:23:06Z","timestamp":1632763386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-046286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,27]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/bmjopen-2020-046286"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-046286","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}